Literature DB >> 11854223

Role of osteopontin in murine Lyme arthritis and host defense against Borrelia burgdorferi.

Melissa R Potter1, Susan R Rittling, David T Denhardt, Randall J Roper, John H Weis, Cory Teuscher, Janis J Weis.   

Abstract

Several genetic loci in the mouse have been identified that regulate the severity of Lyme arthritis. The region of chromosome 5 including the osteopontin (OPN) gene (Opn) has been identified in intercross populations of C3H/HeN x C57BL/6 and C3H/HeJ x BALB/cAnN mice. OPN is of particular interest as it is involved in the maintenance and remodeling of tissue during inflammation, it regulates production of interleukin-10 (IL-10) and IL-12 (cytokines implicated in Lyme arthritis), it is necessary for host control of certain bacterial infections, and mice displaying different severities of Lyme arthritis possess different alleles of the OPN gene. Macrophages and splenocytes from OPN-deficient mice on mixed C57BL/6J-129S or inbred 129S backgrounds were stimulated with the Pam(3)Cys modified lipoprotein from Borrelia burgdorferi, OspA. OPN was not required for OspA-induced cytokine production; however, macrophages from 129S-Opn(-/-) mice displayed a reduced level of IL-10 production. OPN was also not required for resistance to severe arthritis, as B. burgdorferi-infected 129S-Opn(-/-) mice developed mild arthritis, as did their wild-type littermates. Arthritis was more severe in OPN-deficient mice on the mixed C57BL/6J-129S backgrounds than in inbred mice of either strain. This increase was most likely due to a gene(s) closely linked to Opn on chromosome 5 in conjunction with other randomly assorting genes. Deficiency in OPN did not influence the numbers of spirochetes in tissues from B. burgdorferi-infected mice, indicating OPN is not part of the host defense to this pathogen. Interestingly, there was no alteration in the B. burgdorferi-specific antibody isotypes in OPN-deficient mice, indicating that its effect on helper T-cell responses is not relevant to the host response to B. burgdorferi.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854223      PMCID: PMC127811          DOI: 10.1128/IAI.70.3.1372-1381.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  52 in total

Review 1.  Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

Authors:  D T Denhardt; M Noda; A W O'Regan; D Pavlin; J S Berman
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

2.  The Igh-1 sequence of the non-obese diabetic (NOD) mouse assigns it to the IgG2c isotype.

Authors:  R M Martin; A Silva; A M Lew
Journal:  Immunogenetics       Date:  1997       Impact factor: 2.846

Review 3.  Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.

Authors:  A O'Regan; J S Berman
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

4.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

Review 5.  Role of osteopontin in cellular signaling and toxicant injury.

Authors:  D T Denhardt; C M Giachelli; S R Rittling
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

6.  Regulation of no synthesis induced by inflammatory mediators in RAW264.7 cells: collagen prevents inhibition by osteopontin.

Authors:  J Y Tian; E S Sørensen; W T Butler; C A Lopez; M S Sy; N K Desai; D T Denhardt
Journal:  Cytokine       Date:  2000-05       Impact factor: 3.861

7.  Osteopontin is a negative feedback regulator of nitric oxide synthesis in murine macrophages.

Authors:  H Guo; C Q Cai; R A Schroeder; P C Kuo
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Protection of nonobese diabetic mice from diabetes by gene(s) closely linked to IFN-gamma receptor loci.

Authors:  O Kanagawa; G Xu; A Tevaarwerk; B A Vaupel
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

9.  Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.

Authors:  L Glickstein; M Edelstein; J Z Dong
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

10.  Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells.

Authors:  A W O'Regan; J M Hayden; J S Berman
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  8 in total

1.  Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism.

Authors:  Marije Oosting; Frank L van de Veerdonk; Thirumala-Devi Kanneganti; Patrick Sturm; Ineke Verschueren; Anneleen Berende; Jos W M van der Meer; Bart-Jan Kullberg; Mihai G Netea; Leo A B Joosten
Journal:  Eur J Immunol       Date:  2010-12-09       Impact factor: 5.532

2.  Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin.

Authors:  Styliani Antonara; Laura Ristow; James McCarthy; Jenifer Coburn
Journal:  Infect Immun       Date:  2010-08-09       Impact factor: 3.441

3.  Osteopontin impairs host defense during established gram-negative sepsis caused by Burkholderia pseudomallei (melioidosis).

Authors:  Gerritje J W van der Windt; W Joost Wiersinga; Catharina W Wieland; Ivo C S I Tjia; Nicholas P Day; Sharon J Peacock; Sandrine Florquin; Tom van der Poll
Journal:  PLoS Negl Trop Dis       Date:  2010-08-31

4.  Interval-specific congenic lines reveal quantitative trait Loci with penetrant lyme arthritis phenotypes on chromosomes 5, 11, and 12.

Authors:  Ying Ma; Jennifer C Miller; Hillary Crandall; Eric T Larsen; Diane M Dunn; Robert B Weiss; Meenakumari Subramanian; John H Weis; James F Zachary; Cory Teuscher; Janis J Weis
Journal:  Infect Immun       Date:  2009-06-01       Impact factor: 3.441

5.  Anti-p19 antibody treatment exacerbates lyme arthritis and enhances borreliacidal activity.

Authors:  Sara Heil Peterson; Dean T Nardelli; Thomas F Warner; Steven M Callister; Jose R Torrealba; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

6.  Osteopontin is not crucial to protective immunity during murine tuberculosis.

Authors:  Gerritje J W van der Windt; Catharina W Wieland; Willem J Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2009-02-17       Impact factor: 7.397

7.  Osteopontin Deficiency Suppresses Tumor Necrosis Factor-α-Induced Apoptosis in Chondrocytes.

Authors:  K Yumoto; A Nifuji; S R Rittling; Y Tsuchiya; S Kon; T Uede; D T Denhardt; H Hemmi; T Notomi; T Hayata; Y Ezura; T Nakamoto; M Noda
Journal:  Cartilage       Date:  2012-01       Impact factor: 4.634

8.  OspA heterogeneity of Borrelia valaisiana confirmed by phenotypic and genotypic analyses.

Authors:  Karine Ryffel; Olivier Péter; Eric Dayer; Anne-Gabrielle Bretz; Edmond Godfroid
Journal:  BMC Infect Dis       Date:  2003-06-24       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.